OP04 Patient Preferences Regarding Pharmaceutical Services: The Ukrainian Experience Of MaxDiff Analysis

Introduction Incorporating patient preferences into health technology assessment represents a promising avenue for its enhancement. However, the complexity and diversity of methods for evaluating preferences, coupled with uncertainties regarding their impact on decision-making processes, present significant challenges to their effective integration. Consequently, the objective of this study was to evaluate the application of the MaxDiff analysis methodology for determining patient preferences, with a focus on pharmaceutical services as a case study. Methods The experimental design for scaling MaxDiff was developed using Sawtooth Lighthouse software. The design parameters included 12 pharmaceutical services. Descriptive statistics, hierarchical Bayesian analysis, latent class analysis, and logistic regression methods were employed to generate preference results. Results The most preferred services were identified as follows: the creation of a personalized list of safe medications to address patient needs, with a quantitative contribution of 0.5; and the provision of rapid tests (for influenza and Helicobacter ) and stroke risk assessment (quantitative contribution of 0.31). In contrast, patients did not prioritize services related to contraception selection or weight control and weight loss program development. Descriptive statistics, hierarchical Bayesian analysis, and logistic regression methods sequentially identified the most preferred services. Latent class analysis revealed two distinct consumer segments: Segment 1 (39%) and Segment 2 (60%), which differed in their sociodemographic characteristics and preferred services. Conclusions The obtained results can be utilized as patient-based evidence to understand patients’ unmet needs in the assessment of technologies such as pharmaceutical services, taking into account the local context. Despite the simplicity of the MaxDiff analysis methodology, the resource intensity and the level of knowledge among specialists and patients regarding preference collection methods remain significant barriers to its implementation.

Authors

Publication Details

Journal
International Journal of Technology Assessment in Health Care
Published
2025-12-01
DOI
https://doi.org/10.1017/s0266462325100639
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OP04 Patient Preferences Regarding Pharmaceutical Services: The Ukrainian Experience Of MaxDiff Analysis

Tamara Mahanova
International Journal of Technology Assessment in Health Care
Health Systems, Economic Evaluations, Quality of Life
article

OP04 Patient Preferences Regarding Pharmaceutical Services: The Ukrainian Experience Of MaxDiff Analysis

Tamara Mahanova
article en

Abstract

Introduction Incorporating patient preferences into health technology assessment represents a promising avenue for its enhancement. However, the complexity and diversity of methods for evaluating preferences, coupled with uncertainties regarding their impact on decision-making processes, present significant challenges to their effective integration. Consequently, the objective of this study was to evaluate the application of the MaxDiff analysis methodology for determining patient preferences, with a focus on pharmaceutical services as a case study. Methods The experimental design for scaling MaxDiff was developed using Sawtooth Lighthouse software. The design parameters included 12 pharmaceutical services. Descriptive statistics, hierarchical Bayesian analysis, latent class analysis, and logistic regression methods were employed to generate preference results. Results The most preferred services were identified as follows: the creation of a personalized list of safe medications to address patient needs, with a quantitative contribution of 0.5; and the provision of rapid tests (for influenza and Helicobacter ) and stroke risk assessment (quantitative contribution of 0.31). In contrast, patients did not prioritize services related to contraception selection or weight control and weight loss program development. Descriptive statistics, hierarchical Bayesian analysis, and logistic regression methods sequentially identified the most preferred services. Latent class analysis revealed two distinct consumer segments: Segment 1 (39%) and Segment 2 (60%), which differed in their sociodemographic characteristics and preferred services. Conclusions The obtained results can be utilized as patient-based evidence to understand patients’ unmet needs in the assessment of technologies such as pharmaceutical services, taking into account the local context. Despite the simplicity of the MaxDiff analysis methodology, the resource intensity and the level of knowledge among specialists and patients regarding preference collection methods remain significant barriers to its implementation.

International Journal of Technology Assessment in Health CareVol. 41(S1)
Openalex Percentile: Top 21%
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

OP04 Patient Preferences Regarding Pharmaceutical Services: The Ukrainian Experience Of MaxDiff Analysis — Tamara Mahanova · International Journal of Technology Assessment in Health Care (2025) | TGRS Research Map | TGRS